Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 12 Jun 2023 for Revolution Medicines, Inc.. Read the official filing
Filing timeline
BuySaleEric Thomas Schmidt
Insider track record
Disclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Eric Thomas Schmidt: trading record in brief
This profile gathers the share dealings of Eric Thomas Schmidt across 2 companies, led by Allogene Therapeutics, Inc. and Revolution Medicines, Inc. The record holds 8 filings, for trades running from 24 May 2021 to 8 June 2023.
Sales make up the whole of the open-market record (1 sale, €80k). Outside the open market, there are 6 share grants and 1 option exercise.
The newest entry dates from 12 June 2023: a share grant, in Revolution Medicines, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Eric Thomas Schmidt
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations8 total
5,200 shares0Common StockSEC:0001610717-23-000132:0
558,094 shares0Common StockSEC:0001593968-23-000527:0
35,879 shares@ US$5.4737.7% of flowCommon StockSEC:0001737287-23-000024:0
5,200 shares0Common StockSEC:0001567619-22-013110:0
237,358 shares0Common StockSEC:0001214659-22-004371:0
11,469 shares@ US$7.63370.012% mcap26.5% of flowCommon StockSEC:0001214659-22-004084:0
3,617 shares0Common StockSEC:0001567619-21-012591:0
14,897 shares@ US$18.2245.8% of flowCommon StockSEC:0001214659-21-005926:0
8 of 8 declarations
